Function
Human chorionic gonadotropin (hCG) is a glycoprotien hormone secreted by the developing placenta shortly after implantation.
Measuring hCG levels can be helpful in identifying a normal pregnancy, pathologic pregnancy, and can also be useful following an aborted pregnancy. There is also a benefit in measuring hCG in a variety of cancers including choriocarcinoma and extra-uterine malignancies
Smaller amounts of hCG are also produced in the pituitary gland, the liver, and the colon. As previously mentioned, certain malignancies can also produce either hCG or hCG-related hormone.
The hormone itself is a glycoprotein composed of two subunits, the alpha and beta subunits. There are multiple forms found in the serum and urine during pregnancy including the intact hormone and each of the free subunits. HCG is primarily catabolized by the liver, although about 20% is excreted in the urine. The beta subunit is degraded in the kidney to make a core fragment which is measured by urine hCG tests.
Testing
Urine Testing
- Urine should not be collected after the patient has been drinking a large amount of fluid, as a dilute specimen may result in a falsely negative test.
- Blood in the urine may cause a false positive test result.
Serum Testing
- Peripheral blood can be obtained for a serum hCG test
There are multiple reasons why an hCG test (serum or urine) may have a false report. While uncommon, false positive hCG tests can result in unnecessary medical care and/or irreversible surgical procedures. False negatives may be equally concerning and result in a delay in care or diagnostic evaluation. Potential causes of false results are listed and briefly discussed.
Serum False Positives (1/1000 to 1/10,000)
- Ectopic production of hCG (hydatidiform mole, choriocarcinoma, and germ cell tumors, in addition to multiple myeloma, stomach, liver, lung, bladder, pancreatic, breast, colon, cervical, and endometrial cancers)
- Heterophile antibodies (autoantibodies and antibodies formed after exposure to animal products that interact with the assay antibodies)
- Rheumatoid factors (can bind the antibodies in the assay as well)
- IgA deficiency
- Chronic renal failure or ESRD on hemodialysis (rare)
- Red blood cell or plasma transfusion of blood with hCG in it have been reported
- Exogenous hCG preparations for weight loss, assisted reproduction, doping
Serum False Negatives
- Early measurement after conception
- "Hook effect" can occur when hCG levels are about 500,000 mIU/mL.This is because there are so many hCG molecules that they saturate both the tracer and the antibodies separately, which doesn't allow for the sandwiching of the tracer-hCG-antibody required for the measurement. This means that all of the complexes are washed away, giving a false-negative result. If gestational trophoblastic disease is suspected, the lab should perform a dilution prior to testing.
Urine False Positives
- Blood or protein in the urine
- Human error in result interpretation
- Ectopic production of hCG
- Exogenous hCG
- Drugs (aspirin, carbamazepine, methadone, high urinary pH and seminal fluid)
Urine False Negatives
- Early measurement after conception
- Dilute urine specimen
- "Hook effect" as discussed above
HCG in the serum increases with age in nonpregnant women. A cut off of 14 mIU/mL has been suggested for use in interpreting results in women over the age of 55. In all nonpregnant patients, testicular cancer, ovarian cancer, bladder cancer, or other malignancy should be evaluated as a source of persistently positive hCG testing
Gestational Trophoblastic Disease
is a group of rare diseases in which abnormal trophoblast cells grow inside the uterus after conception(the joining of sperm and egg).
Detection of hCG is also useful in the evaluation of trophoblastic disease, including complete and partial hydatidiform mole, postmolar tumor, gestational choriocarcinoma, testicular choriocarcinoma, and placental site trophoblastic disease. All of these entities produce hCG, varying levels of which are reported on commercial assays. A total hCG level of greater than 100,000 mIU/mL in early pregnancy, for example, is highly suggestive of a complete hydatidiform mole, although many normal pregnancies may reach this level at their peak around weeks 8 to 11 of gestation. Precise hCG measurements are important to assess the tumor mass, the successful treatment of malignancy, and to test for recurrence or persistence of disease
Weeks of Pregnancy |
Range mUI/ml |
3 4 5 6 7 8 9 10 12 14 15 16 17 18 <5 |
5.8-71.2 9.5-750 217-7138 158-31,795 3697-163,563 32,065-149,571 63,803-151,410 46,509-186,977 27,832-210,612 13,950-62,530 12,093-70,971 9040-56,451 8175-55,868 8099-58176 Non-Pregnacy |
References
https://www.ncbi.nlm.nih.gov/books/NBK532950/
https://en.wikipedia.org/wiki/Human_chorionic_gonadotropin
Comments